Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Molecular & Cellular Proteomics : MCP|October 21, 2024
Nanobodies: From High-Throughput Identification to Therapeutic DevelopmentPeter C Fridy, Michael P Rout, Natalia E Ketaren
The Journal of Biological Chemistry|August 11, 2007
Cloning and characterization of two human VIP1-like inositol hexakisphosphate and diphosphoinositol pentakisphosphate kinasesPeter C Fridy, James C Otto, D Eric Dollins, et al.
Analytical Biochemistry|February 25, 2015
Engineered high-affinity nanobodies recognizing staphylococcal Protein A and suitable for native isolation of protein complexesPeter C Fridy, Mary K Thompson, Natalia E Ketaren, et al.
Journal of Immunological Methods|January 19, 2016
Optimizing selection of large animals for antibody production by screening immune response to standard vaccinesMary K Thompson, Peter C Fridy, Sarah Keegan, et al.
Methods in Enzymology|October 24, 2007
Biochemical analysis of inositol phosphate kinasesJames C Otto, Sashidhar Mulugu, Peter C Fridy, et al.
Science (New York, N.Y.)|April 7, 2007
A conserved family of enzymes that phosphorylate inositol hexakisphosphateSashidhar Mulugu, Wenli Bai, Peter C Fridy, et al.
Biorxiv : the Preprint Server for Biology|July 28, 2023
Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virusNatalia E Ketaren, Fred D Mast, Peter C Fridy, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2020
Vip1 is a kinase and pyrophosphatase switch that regulates inositol diphosphate signalingD Eric Dollins, Wenli Bai, Peter C Fridy, et al.
Nature Methods|October 6, 2015
A strategy for dissecting the architectures of native macromolecular assembliesYi Shi, Riccardo Pellarin, Peter C Fridy, et al.
Pageof 3